Vaginal dryness, irritation, pruritus, urinary symptoms and painful intercourse. THEY ARE SYMPTOMS
Conditions
Interventions
Intervention group:The fractional microablative CO2 laser system (SmartXide 2 V 2 LR, Monalisa Touch, DEKA, Florence, Italy) was applied. Laser energy was transmitted through a vaginal probe, the frac
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: postmenopausal woman aged 45 to 65 years with symptoms of vaginal atrophy that lasts more than 24 months after menopause. Vaginal dryness, irritation, pruritus, urinary symptoms and painful intercourse
Exclusion criteria
Exclusion criteria: Hormone therapy (topical or systemic) in the last 12 months• Use of vaginal moisturizers and gels• Genitourinary infection (Vulvovaginitis)• Women who use psychotropic drugs• BMI higher than 35• Current cancer history• Abnormal Pap smear• Menopause induced by medication• History of steroid use• History of vaginal radiotherapy in the past
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect the quality of life that measure with standard devices (The questionnaire of quality of life questionnaire (SF-12), the Incontinence Questionnaire-Short Form (ICIQ-SF), the Female Sex Function Index6- The Menopause-Specific Quality of Life) will change in our study. Timepoint: At the beginning of the study and 4 weeks after the last treatment. Method of measurement: standard questionnaire that are validated in Iran. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarjan Ghaemi
Tehran University of Medical Sciences
Outcome results
None listed